Dysregulated pathways in comparison of patients with AS and unaffected controls according to Ingenuity Pathway Analysis.
| Canonical Pathways | p |
|---|---|
| Nuclear factor-κB signaling | 0.0006 |
| Dendritic cell maturation | 0.008 |
| Toll-like receptor signaling | 0.008 |
| TREM1 signaling | 0.01 |
| BRCA1 in DNA damage response | 0.009 |